Gamma-Glutamylcysteine Synthetase Deficiency, Hemolytic Anemia due to
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
2
|
0.700 |
strong |
1.000 |
6 |
2
|
1996 |
2016 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
38
|
0.500 |
None |
1.000 |
1 |
|
2007 |
2009 |
Anemia, Hemolytic
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
13
|
7
|
0.430 |
None |
1.000 |
1 |
|
1999 |
2007 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
266
|
173
|
0.350 |
None |
1.000 |
1 |
|
1997 |
2017 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
883
|
1629
|
0.320 |
None |
0.500 |
2 |
|
2007 |
2011 |
Non-Small Cell Lung Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
156
|
132
|
0.320 |
None |
1.000 |
1 |
|
2004 |
2019 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
95
|
162
|
0.320 |
None |
1.000 |
1 |
|
2003 |
2011 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
190
|
233
|
0.320 |
None |
1.000 |
1 |
|
2007 |
2019 |
Lung Neoplasms
|
group |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
265
|
|
0.310 |
None |
1.000 |
1 |
|
2002 |
2017 |
Myocardial Ischemia
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
176
|
|
0.310 |
None |
1.000 |
1 |
|
2005 |
2017 |
Enzymopathy
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
11
|
|
0.300 |
strong |
1.000 |
2 |
|
1996 |
1999 |
Glutamate-cysteine ligase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
strong |
1.000 |
2 |
|
1996 |
1999 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
1
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Amino Acid Metabolism, Inherited Disorders
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Microangiopathic hemolytic anemia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Anemia, Hemolytic, Acquired
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
13
|
1
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Anemia, Microangiopathic
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Neoplastic Cell Transformation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
139
|
|
0.300 |
None |
1.000 |
1 |
|
2019 |
2019 |
Coronary Vessel Anomalies
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Contact Dermatitis
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
404
|
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Amino Acid Metabolism, Inborn Errors
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
13
|
|
0.300 |
None |
1.000 |
1 |
|
1999 |
1999 |
Contact hypersensitivity
|
phenotype |
Skin and Connective Tissue Diseases
|
Pathologic Function
|
71
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |